00, p = 0.010), longer time to its diagnosis (7.00 ± 4.50 vs. 5.00 ± 2.00, p = 0.014), higher hemoglobin levels (13.20 ± 1.15 vs. 12.40 ± 0.90, p = 0.010) and MCH (29.40 ± 2.00 vs. 27.70 ± 2.05, p = 0.022) relative to patients without overweight/obesity. This evidence concerns the gene PMCH and obesity disorder.